Page 4 - Accelerated Access Collaborative News Today : Breaking News, Live Updates & Top Stories | Vimarsana

We're looking for your views and comments on our proposed legislative changes to clarify the legal basis for EAMS.

6 April 2021 The MHRA is committed to speeding up access to innovative new medicines for patients. The Early Access to Medicines Scheme (EAMS) gives patients with life threatening or seriously debilitating conditions access to medicines that do not yet have a marketing authorisation when there is a clear unmet medical need. The scheme has remained fully operational throughout the coronavirus (COVID-19) pandemic, ensuring that patients with serious conditions can still be offered new treatment options for their conditions. As an example, the MHRA issued a positive scientific opinion for Roche�...

Increased access to Mavenclad (cladribine tablets) for Multiple Sclerosis patients in Response to the COVID-19 Pandemic NHS England responds to the COVID-19 pandemic by simplifying eligibility requirements for patients with highly active relapsing MS starting cladribine tabletsAmends made to Blueteq form suspen...

Patients with diabetes and high blood pressure are benefiting from pioneering artificial intelligence (AI) that turns a smartphone camera into a clinical-grade tool to detect early kidney disease.

Smartphone technology in bid to revolutionise early detection of kidney disease Thousands of patients to benefit from smartphone app that allows them to transmit results to their GP in minutes without leaving home. From: AI) that turns a smartphone camera into a clinical-grade tool to detect early kidney disease. NHSX, the digital transformation arm of the NHS, is supporting Healthy.io to offer 500,000 patients technology-supported home-testing kits over the next 3 years. More than 3,500 patients have already received their kits. Patients taking part receive a simple test kit and smartpho...